TL
Laumonier, Thomas
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Intracellular autofluorescence enables the isolation of viable, functional human muscle reserve cells with distinct Pax7 levels and stem cell states | Stem cell research & therapy |  | 2025 | 20 | 9 | ||
| Alerte au feu : des nanopompiers pour combattre les flammes de la polyarthrite rhumatoïde | Revue médicale suisse |  | 2024 | 194 | 13 | ||
| Platelet-rich plasma promotes the expansion of human myoblasts and favors the in vitro generation of human muscle reserve cells in a deeper state of quiescence | Stem cell reviews and reports | | 2024 | 84 | 65 | ||
| Synthetic injectable and porous hydrogels for the formation of skeletal muscle fibers : Novel perspectives for the acellular repair of substantial volumetric muscle loss | Journal of tissue engineering | | 2024 | 90 | 37 | ||
| Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups : A histopathological cohort study | Journal of neuropathology and experimental neurology | | 2024 | 81 | 99 | ||
| Identification of a muscle-specific isoform of VMA21 as a potent actor in X-linked myopathy with excessive autophagy pathogenesis | Human molecular genetics | | 2023 | 147 | 172 | ||
| Voyage sur la banquise : une perspective de traitement contre le cancer ? | Revue médicale suisse | | 2023 | 133 | 84 | ||
| NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice | RMD open | | 2023 | 244 | 117 | ||
| In vitro-generated human muscle reserve cells are heterogeneous for Pax7 with distinct molecular states and metabolic profiles | Stem cell research & therapy | | 2023 | 204 | 35 | ||
| Muscle stem cell-based therapiesin the treatment of skeletal muscle injury and disease | | 2022 | 228 | 12 | |||
| Seul au monde : le naufrage de l’immunité antivirale | Revue médicale suisse | | 2022 | 102 | 151 | ||
| Immortalised human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology | Molecular therapy. Methods & clinical development | | 2022 | 249 | 167 | ||
| Noix de cajou: un incontournable de l'apéro pour guérir la sclérose en plaques ? | Revue médicale suisse | | 2021 | 548 | 382 | ||
| Accoutumance à la morphine : probiotiques à la rescousse | Revue médicale suisse | | 2021 | 423 | 686 | ||
| Human myoblasts differentiate in various mesenchymal lineages and inhibit allogeneic T cell proliferation through an indolamine 2,3 dioxygenase dependent pathway | Experimental cell research | | 2021 | 307 | 187 | ||
| In vitro evaluation of human myoblast function after exposure to cobalt and chromium ions | Journal of Orthopaedic Research | | 2020 | 413 | 4 | ||
| La conception: une affaire de protéines | Revue médicale suisse | | 2020 | 314 | 271 | ||
| Use of supercritical carbon dioxide technology for fabricating a tissue engineering scaffold for anterior cruciate ligament repair | Scientific Reports | | 2020 | 296 | 277 | ||
| Human myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient mice | Scientific Reports | | 2017 | 597 | 354 | ||
| Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement | Journal of Visualized Experiments | 2017 | 574 | 0 | |||
| Muscle injuries and strategies for improving their repair | Journal of Experimental Orthopaedics | | 2016 | 534 | 478 | ||
| Basic Principles of Muscle Healing | Acute muscle injuries | 2014 | 615 | 0 | |||
| Low molecular weight dextran sulfate binds to human myoblasts and improves their survival after transplantation in mice | Cell transplantation | | 2013 | 626 | 3 | ||
| Autologous transplantation of culture-born myofibroblasts into intact and injured rabbit ligaments | International orthopaedics | | 2012 | 602 | 497 | ||
| Regenerative medicine for cartilage | The knee joint. Surgical techniques and strategies | | 2012 | 583 | 0 | ||
| α-Smooth muscle actin and TGF-β receptor I expression in the healing rabbit medial collateral and anterior cruciate ligaments | Injury | | 2011 | 642 | 0 | ||
| "Biological failure" of the anterior cruciate ligament graft | Knee surgery, sports traumatology, arthroscopy | | 2008 | 646 | 1,106 | ||
| Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig | Molecular therapy | | 2008 | 650 | 2 | ||
| Myogenic precursor cell transplantation in pigs: a step towards a clinical use for muscle regeneration? | Schweizerische medizinische Wochenschrift | 2007 | 876 | 0 | |||
| Autologous transplantation of porcine myogenic precursor cells in skeletal muscle | Neuromuscular disorders | | 2005 | 884 | 0 | ||
| Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models | Xenotransplantation | | 2004 | 538 | 0 | ||
| Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum | Xenotransplantation | | 2004 | 709 | 0 | ||
| Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation | American journal of transplantation | | 2004 | 524 | 0 | ||
| Nouvelles approches thérapeutiques des lésions musculaires: du problème clinique à la recherche | Médecine et hygiène | | 2004 | 792 | 1 | ||
| Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells | Transplantation | | 2003 | 592 | 0 | ||
| CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression | Human gene therapy | | 2003 | 649 | 0 | ||
| New concepts in organ preservation | Transplant immunology | | 2002 | 619 | 0 | ||
| Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression | The Journal of immunology | | 2000 | 655 | 0 |
